Ipca Laboratories (Ipca) has announced that following a review of the FDA warning letter issued to the company recently, the Global Fund has decided to not allocate any Institutional Malaria volumes to it.
We recently met the top management of Jubilant Foodworks (JFL). While the company attributed 80% of the slowdown in same stores sales growth (SSG) to macro factors, competition from non-pizza offerings/online ordering apps wa
IL&FS Transportation’s (ITNL) Q3FY16 results were boosted by stake sale in subsidiary. Revenue, at R2,190 crore (up 12% y-o-y), was aided by the R310 crore revenue booked from stake sale in Rapid Metro project.
Glenmark Pharmaceuticals’ (GNP) Q3FY16 sales grew 4%, while EBITDA remained flat (we have not adjusted for forex loss of Rs 270 million as this pertains to normal business) and PAT declined 23% y-o-y (high tax rate): North
Maintain ‘reduce’ on DCB Bank with a target price of Rs 86 per share. DCB has posted remarkable turnaround, but up-fronting of cost structure will strain return ratios and the breakeven of these costs will hold key